November 1, 2012 -- Sihuan Pharmaceutical reported that its new gastrointestinal generic drug, Roxatidine Acetate Hydrochloride for Injection, received SFDA approval. As a first-to-market generic, it will enjoy four years of exclusivity in China. The drug, which was approved in both oral and injectible forms, is a treatment for ulcers and GI bleeding. More details....
